|
Volumn 36, Issue 5, 1999, Pages 467-476
|
Development of 18F-FDG ([F-18]-2-fluoro-2-deoxy-D-glucose) injection for imaging of tumor reflecting glucose metabolism - Results of preclinical studies
a a a a a a a a |
Author keywords
18F FDG; Biodistribution; MIRD; PET; Preclinical studies
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
GLUCOSE;
RADIOPHARMACEUTICAL AGENT;
DIAGNOSTIC AGENT;
FLUORINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BRAIN;
COLON TUMOR;
DOG;
DRUG DISTRIBUTION;
GLUCOSE METABOLISM;
HEART;
HUMAN;
IMAGING SYSTEM;
INTRAVENOUS DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
RADIATION DOSE;
RADIOACTIVITY;
RAT;
ANIMAL;
BAGG ALBINO MOUSE;
DRUG SCREENING;
EXPERIMENTAL NEOPLASM;
FEMALE;
MALE;
METABOLISM;
RABBIT;
SPRAGUE DAWLEY RAT;
TISSUE DISTRIBUTION;
ANIMALS;
DOGS;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
FLUORINE RADIOISOTOPES;
FLUORODEOXYGLUCOSE F18;
INJECTIONS, INTRAVENOUS;
MALE;
MICE;
MICE, INBRED BALB C;
NEOPLASMS, EXPERIMENTAL;
RABBITS;
RADIATION DOSAGE;
RADIOPHARMACEUTICALS;
RATS;
RATS, SPRAGUE-DAWLEY;
TISSUE DISTRIBUTION;
|
EID: 0032589212
PISSN: 00227854
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (2)
|